Literature DB >> 2210767

Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).

.   

Abstract

In this collaborative European study, a total of 4871 cystic fibrosis (CF) chromosomes and 3539 normal chromosomes have been characterized for the haplotypes defined by the 2 extragenic polymorphic sequences revealed by XV2c and KM19. The association between one of these haplotypes (B haplotype) and the most frequent CF mutation, delta F508, suggests for the latter a single origin and a subsequent diffusion according to a South East-North West gradient. The linkage disequilibrium data between CF and the B haplotype in different European populations are compatible with a relatively more recent appearance of the mutation in Northern Europe whereas in Southern Europe a longer history of the same mutation would have allowed time for recombination with other haplotypes. This model is also compatible with a selective advantage of carriers but does not account for (1) the excess of B haplotypes observed among both normal and non-delta F508 CF chromosomes; (2) the correlation between the B haplotype and the severity of the phenotypic effect caused by CF mutations, as measured by pancreatic insufficiency and meconium ileus.

Entities:  

Mesh:

Year:  1990        PMID: 2210767     DOI: 10.1007/bf02428304

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  72 in total

1.  First-trimester prenatal diagnosis of cystic fibrosis by direct gene probing.

Authors:  I McIntosh; J A Raeburn; A Curtis; D J Brock
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

2.  The molecular basis of beta thalassaemia in Bulgaria.

Authors:  L Kalaydjieva; A Eigel; J Horst
Journal:  J Med Genet       Date:  1989-10       Impact factor: 6.318

3.  Confirmation of linkage disequilibrium between haplotype B (XV-2c, allele 1; KM-19, allele 2) and cystic fibrosis allele in the French population.

Authors:  M Vidaud; A Kitzis; C Ferec; D Bozon; V Dumur; G Giraud; F David; O Pascal; M Auvinet; Y Morel
Journal:  Hum Genet       Date:  1989-01       Impact factor: 4.132

4.  Linkage disequilibrium in finite populations.

Authors:  W G Hill; A Robertson
Journal:  Theor Appl Genet       Date:  1968-06       Impact factor: 5.699

5.  Synthetic maps of human gene frequencies in Europeans.

Authors:  P Menozzi; A Piazza; L Cavalli-Sforza
Journal:  Science       Date:  1978-09-01       Impact factor: 47.728

6.  Same-day, first-trimester antenatal diagnosis for cystic fibrosis by gene amplification.

Authors:  C Williams; R Williamson; C Coutelle; F Loeffler; J Smith; A Ivinson
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

Review 7.  The origin of mutant beta-globin genes in human populations.

Authors:  J S Wainscoat
Journal:  Acta Haematol       Date:  1987       Impact factor: 2.195

8.  [Neonatal screening for cystic fibrosis].

Authors:  J Isolauri; J Uitti; J K Visakorpi
Journal:  Duodecim       Date:  1979

9.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  Haplotype analysis of the phenylalanine hydroxylase gene in Turkish phenylketonuria families.

Authors:  M Stuhrmann; O Riess; E Mönch; G Kurdoglu
Journal:  Clin Genet       Date:  1989-08       Impact factor: 4.438

View more
  29 in total

1.  Can a place of origin of the main cystic fibrosis mutations be identified?

Authors:  Eva Mateu; Francesc Calafell; Maria Dolors Ramos; Teresa Casals; Jaume Bertranpetit
Journal:  Am J Hum Genet       Date:  2001-11-16       Impact factor: 11.025

2.  Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis families.

Authors:  T Dörk; T Neumann; U Wulbrand; B Wulf; N Kälin; G Maass; M Krawczak; H Guillermit; C Ferec; G Horn
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

3.  Frequency of delta F508 mutation and haplotype analysis in Austrian cystic fibrosis families.

Authors:  J Larsen; A Georghiou; F D Kury; M Götz; K Sanz; K Dobianer; J Spona
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

4.  Carrier detection and prenatal diagnosis of cystic fibrosis using an intragenic TA-repeat polymorphism.

Authors:  E Mornet; C Chateau; B Simon-Bouy; J Boue; J Zielenski; L C Tsui; A Boue
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

5.  Analysis of 30 known cystic fibrosis mutations: 10 mutations account for 27% of non-delta F508 chromosomes in southern France.

Authors:  M Claustres; M Desgeorges; P Kjellberg; C Tissot; J Demaille
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

6.  Frequency of the F508 deletion in cystic fibrosis patients from the European part of the USSR.

Authors:  V S Baranov; T E Ivaschenko; V N Gorbunova; L A Livshitz; M T Venozinskis; S A Gembovskaya; V N Kalinin; O P Romanenko; T E Gembitzkaya; A V Orlov
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

7.  Frequency of the delta F508 deletion and G551D, R553X and G542X mutations in Yugoslav CF patients.

Authors:  B B Dabović; D Radojković; P Minić; J Savić; A Savić
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

8.  Discrimination between recurrent mutation and identity by descent: application to point mutations in exon 11 of the cystic fibrosis (CFTR) gene.

Authors:  J Reiss; D N Cooper; J Bal; R Slomski; G R Cutting; M Krawczak
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

Review 9.  Spectrum of mutations in cystic fibrosis.

Authors:  G R Cutting
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

10.  Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: detection of 90% of molecular defects and identification of three novel mutations.

Authors:  V Brancolini; L Cremonesi; E Belloni; E Pappalardo; R Bordoni; M Seia; S Russo; R Padoan; A Giunta; M Ferrari
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.